{"id":"a0bb956c-fcf2-4374-b893-42388bad22be","name":"MMI (Medical Microinstruments)","slug":"mmi-symani","description":"Italian-founded surgical robotics company developing the [Symani](/models/symani-surgical-system) Surgical System, the first robotic platform for open soft-tissue microsurgery. MMI's NanoWrist instruments are the world's smallest wristed surgical robotic instruments, enabling tremor filtration and motion scaling for procedures on vessels as small as 0.3mm. Founded in 2015 near Pisa, Italy, MMI received FDA De Novo authorization in April 2024 and CE mark in 2019, with ~1,000 clinical cases completed in Europe.","status":"private","founded":2015,"hq":"Jacksonville, Florida, USA","hqLat":30.3262247,"hqLng":-81.6579179,"hqGeocodedAt":"2026-08-05T14:38:04.360Z","hqAddress":null,"hqPrecision":null,"website":"https://www.mmimicro.com/","fundingTotal":"211000000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":75,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://mmimicro.com","label":"MMI"}],"keyFacts":[{"label":"CEO","value":"Mark Toland"},{"label":"Founded","value":"2015 near Pisa, Italy"},{"label":"HQ","value":"Jacksonville, Florida (US redomicile 2022); R&D and manufacturing in Pisa."},{"label":"Product","value":"Symani robotic microsurgery system with 7-DoF NanoWrist instruments."},{"label":"NanoWrist (company-claimed)","value":"World's smallest wristed surgical robotic instruments."},{"label":"FDA (Apr 2024)","value":"De Novo authorization for reconstructive microsurgery."},{"label":"CE mark (2019)","value":"Commercial in Europe and parts of Asia Pacific."},{"label":"Clinical cases","value":"About 1,000 in the EU; first US cases in 2024."},{"label":"Funding","value":">$200M: seed $2M (2016), A $24M (2018), B $75M (2022), C $110M (2024)."},{"label":"Key investors","value":"Fidelity (C lead), Deerfield (B lead), RA Capital, Andera, Fountain, Panakes, Wellington"},{"label":"REMIND study","value":"First robotic microsurgery study in Alzheimer's; IDE Nov 2025, first patient May 2026."}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-18T03:17:11.021Z","updatedAt":"2026-10-12T22:59:29.201Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/mmi-symani","url":"https://registry.deploy.report/companies/mmi-symani","name":"MMI (Medical Microinstruments)","description":"Italian-founded surgical robotics company developing the [Symani](/models/symani-surgical-system) Surgical System, the first robotic platform for open soft-tissue microsurgery. MMI's NanoWrist instruments are the world's smallest wristed surgical robotic instruments, enabling tremor filtration and motion scaling for procedures on vessels as small as 0.3mm. Founded in 2015 near Pisa, Italy, MMI received FDA De Novo authorization in April 2024 and CE mark in 2019, with ~1,000 clinical cases completed in Europe.","identifier":"a0bb956c-fcf2-4374-b893-42388bad22be","foundingDate":"2015","address":"Jacksonville, Florida, USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}